Drug Shortage Report for MYLAN-ATENOLOL
Report ID | 125 |
Drug Identification Number | 02146894 |
Brand name | MYLAN-ATENOLOL |
Common or Proper name | ATENOLOL |
Company Name | MYLAN PHARMACEUTICALS ULC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | ATENOLOL |
Strength(s) | 50MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100BT, 500BT |
ATC code | C07AB |
ATC description | BETA BLOCKING AGENTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2018-07-03 |
Actual start date | 2018-07-03 |
Estimated end date | Unknown |
Actual end date | 2018-07-03 |
Shortage status | Resolved |
Updated date | 2018-07-05 |
Company comments | Discontinued in ID 51248 |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v23 | 2018-07-05 | French | Compare |
v22 | 2018-07-05 | English | Compare |
v21 | 2018-07-04 | English | Compare |
v20 | 2018-07-03 | French | Compare |
v19 | 2018-07-03 | English | Compare |
v18 | 2018-06-04 | French | Compare |
v17 | 2018-06-04 | English | Compare |
v16 | 2017-08-31 | French | Compare |
v15 | 2017-08-31 | English | Compare |
v14 | 2017-06-22 | French | Compare |
v13 | 2017-06-22 | English | Compare |
v12 | 2017-06-22 | English | Compare |
v11 | 2017-06-22 | English | Compare |
v10 | 2017-06-19 | French | Compare |
v9 | 2017-06-19 | English | Compare |
v8 | 2017-05-26 | French | Compare |
v7 | 2017-05-26 | English | Compare |
v6 | 2017-05-03 | French | Compare |
v5 | 2017-05-03 | English | Compare |
v4 | 2017-03-14 | French | Compare |